Search results
Ozempic Just Got Even More Bullish For Novo Nordisk Stock, Yet Again
Motley Fool via Yahoo Finance· 1 day agoThe medicine for type 2 diabetes called Ozempic is, without a doubt, Novo Nordisk's (NYSE: NVO)...
The disproportionate toll that COVID-19 took on people with diabetes continues today
The Conversation via Yahoo News· 1 day agoHundreds of millions of people worldwide have diabetes. Halfpoint Images/Moment via Getty Images At...
Oral semaglutide could also help treat diabetes, cardiovascular issues
Medical News Today· 2 days agoA new clinical trial in Italy investigates the efficacy of oral semaglutide. Semaglutide and other...
A look at how Ozempic works for weight loss and the problems it may create
CBS News· 9 hours agoOne such weight loss patient, Lisa, heads into her monthly checkup at Dr. Ian Yip's Woodland hills...
Timing key for type 2 diabetes drug performance | Newswise
Newswise· 10 hours agoResearchers from the University of Adelaide could be closer to discovering a better way to use...
The disproportionate toll that COVID-19 took on people with diabetes continues today
San Francisco Chronicle· 1 day agoDiabetes was already known to put people at higher risks from other infectious diseases, including flu. COVID-19 hasn’t disappeared, however, and for the more than 400 million ...
The Disproportionate Toll That COVID-19 Took on People With Diabetes Continues Today
Skanner· 18 hours agoAt the start of the pandemic, many people living with diabetes were wondering what COVID-19 meant for them. COVID-19 hasn’t disappeared, however, and for the more than 400 ...
The disproportionate toll that COVID-19 took on people with diabetes continues today
Stamford Advocate· 1 day agoDiabetes was already known to put people at higher risks from other infectious diseases, including flu. COVID-19 hasn’t disappeared, however, and for the more than 400 million ...
Brookline Capital starts SAB Biotherapeutics stock with $8 PT, buy rating By Investing.com
Investing.com· 3 hours agoThe firm is optimistic about the company's developmental therapy SAB-142, which is aimed at...
This Pharma Stock Dropped 60% Premarket As FDA Halted Diabetes Drug Trials - Biomea Fusion...
Benzinga· 5 hours agoWhat Happened: The FDA’s decision was driven by concerns over potential drug-induced hepatotoxicity...